Serological Pipettes Market

Global Serological Pipettes Market Size (2023 to 2028)

The size of the global serological pipettes market is estimated to grow at a CAGR of 5.12% from 2023 to 2028 and be worth USD 273.1 million by 2028 from USD 212.7 million in 2023.

Global Serological Pipettes Market Share Insights:

• Based on product, the 1-2 ml segment held the leading share of the global market in 2022.
• Based on material, the plastic segment dominated the market in 2022.
• Based on application, the tissue culture segment led the market in 2022.
• Based on end-user, the academic and research institutes segment had the major share of the global market in 2022.
• Based on region, North America held the largest share of the global market in 2022.

Impact of COVID-19 on the global serological pipettes market:

The global healthcare industry, including the serological pipettes market, has been significantly impacted by the COVID-19 pandemic. The pandemic has increased demand for COVID-19-related testing, diagnostics, and research, directly impacting the serological pipettes market. As the world confronted the virus’s rapid spread, pervasive testing became essential for identifying and tracking cases, determining the disease's prevalence, and guiding public health measures. The increased demand for testing in hospitals and clinical laboratories has increased the adoption and utilization of serological pipettes.

Additionally, COVID-19-related research and development efforts have increased the demand for serological pipettes. Scientists and researchers around the globe have been working tirelessly to develop vaccines and therapies and to gain a deeper understanding of the virus. Serological pipettes are indispensable for numerous scientific applications, such as sample preparation, cell culture, and liquid transfer.

However, it is essential to note that the COVID-19 pandemic has also posed challenges for the serological pipettes market. Manufacturing facilities experienced intermittent shutdowns, a lack of raw materials, and transportation restrictions, which caused disruptions and delays in the supply chain. These obstacles have strained the availability of serological pipettes, particularly during the pandemic's apex.

MARKET DRIVERS:

The rising demand for diagnostic testing in the healthcare industry is one of the key factors propelling the global serological pipettes market. Diagnostic testing has increased due to the rising prevalence of chronic diseases and the need for early detection and prevention. In clinical laboratories and hospitals, serological pipettes are commonly used for sample collection, liquid handling, and precise dispensing of reagents and samples. The precision and dependability of serological pipettes enhance diagnostic results and patient care.

Technological advancements in serological pipettes boost market growth. Manufacturers are perpetually innovating to improve the performance and usability of these pipettes. For instance, there are pipettes with ergonomic designs, adjustable volumes, electronic controls, and automated dispensing. These advancements enhance the user experience, reduce the possibility of errors, and increase laboratory workflow efficiency.

The growing number of research and development activities across various scientific disciplines drive the growth of the serological pipettes market. Serological pipettes are indispensable in pharmaceuticals, biotechnology, life sciences, and academic research for sample preparation, cell culture, drug discovery, and molecular biology experiments. There is a growing demand for accurate and precise liquid handling instruments, such as serological pipettes, as scientific knowledge and the need for innovative solutions advance.

MARKET RESTRAINTS:

The presence of alternative liquid handling methods and technologies hinders the growth of the serological pipettes market. Other liquid handling options, such as automated pipetting systems, multichannel pipettes, and disposable pipettes, are available in addition to serological pipettes, which are widely used and acknowledged for their accuracy and convenience. For applications, these alternatives offer performance, throughput, and usability advantages. Consequently, some end-users may opt for these alternatives, reducing the demand for serological pipettes in particular settings.

The stringent regulatory environment is a major restraint for the serological pipettes market. The production, distribution, and use of serological pipettes are governed by numerous regulations and standards established by regulatory agencies such as the Food and Drug Administration (FDA) and the International Organisation for Standardisation (ISO). Compliance with these regulations increases the complexity and expense of product development and marketing. This can inhibit product innovation and create entry barriers for small-scale players.

REPORT COVERAGE:

This research report on global serological pipettes market has been segmented and sub-segmented based on the following categories.

Serological Pipettes Market - By Product:

• 1-2 ml
• 5 ml
• 10 ml
• 25 ml
• Other (50 ml etc.)

Based on product, the 1-2 ml segment is expected to account for the major share of the global market during the forecast period. The versatility and widespread usage in various laboratory applications of 1-2 ml serological pipettes, growing demand for precision liquid handling in diagnostic and research labs and expanding biotechnology and pharmaceutical industries that necessitates precise and small volume pipetting majorly drive the growth of the 1-2 ml serological pipettes segment in the global market.

The 10 ml segment is another lucrative segment and is anticipated to account for a substantial global market share during the forecast period. The growing utilization of 10 ml serological pipettes in various routine laboratory procedures, rising prevalence of chronic diseases requiring diagnostic testing that fuel the need for accurate pipetting and growing applications in drug discovery and development processes primarily drive the growth of the 10 ml segment worldwide.

Serological Pipettes Market - By Material:

• Glass Pipettes
• Plastic Pipettes
• Polystyrene Pipettes
• Others

Based on material, the plastic segment is expected to capture the largest global market share in the coming years. The convenience, cost-effectiveness, and disposability of plastic pipettes majorly drive the adoption of these products and propel segmental growth. The growing demand for plastic pipettes in clinical diagnostics, molecular biology, and cell culture applications, rapidly growing biotechnology and pharmaceutical industries requiring cost-effective and disposable pipettes and increasing preference for plastic pipettes in point-of-care testing and other medical settings due to convenience and reduced risk of contamination further drive the growth of the plastic pipettes segment in the global market.

The glass segment is estimated to witness a healthy CAGR during the forecast period owing to the continuous usage of glass pipettes in specialized laboratory procedures and applications that demand chemical and thermal resistance. Niche applications in research and academic labs for certain precise and delicate procedures and rapid adoption in laboratories where reusable and autoclavable pipettes are preferred for sustainability and cost-saving purposes fuel the growth of the glass pipettes segment in the global market.

Serological Pipettes Market - By Application:

• Tissue Culture
• Bacterial Culture
• Testing Lab
• Others

Based on application, the tissue culture segment is expected to hold the leading share of the global market during the forecast period. The growing usage of tissue culture in research and clinical laboratories for handling and transferring cells and tissues in culture and rising emphasis on cell-based therapies and regenerative medicine driving demand for tissue culture applications and propel the segmental growth. Growing investments in life sciences research and drug development that require extensive cell culture work and increasing demand for accurate and reliable tools to handle delicate cell lines that make serological pipettes an essential tool further drive the growth of the tissue culture segment in the global market.

The bacterial culture segment is anticipated to account for a substantial share of the global market in the coming years owing to the rising demand for microbiological testing and research in various industries, including food, pharmaceuticals, and environmental testing and the emergence of antimicrobial resistance and infectious diseases necessitating increased bacterial culture studies.

Serological Pipettes Market - By End User:

• Hospitals
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others

Based on end-user, the academic and research institutes segment is expected to occupy the leading share of the global market during the forecast period owing to the growing investments in research and development activities by academic institutions, universities, and government funding agencies. The rising focus on life sciences research, including genomics, proteomics, and cell biology that drive the demand for serological pipettes and continuous advancements in medical and biological research that necessitates accurate liquid handling for reproducible results further boost the growth of the academic and research institutes segment in the global market.

Serological Pipettes Market - By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America dominated the market in 2022, and the regional market's domination is expected to continue during the forecast period. The growing number of research and development activities in the pharmaceutical and biotechnology sectors is driving demand for serological pipettes for precise liquid handling in laboratories and propelling the North American market growth. High investments in healthcare infrastructure, emphasis on accurate diagnostics, and strong government support for healthcare and research initiatives further fuel the growth rate of the North American market. The U.S. is one of the largest markets for serological pipettes and is expected to occupy the major share of the North American market in the coming years owing to the presence of advanced healthcare infrastructure, high adoption of innovative laboratory technologies and a well-established pharmaceutical and biotechnology industry.

Europe is predicted to capture a considerable share of the worldwide market in the coming years. Factors such as the growing demand for serological pipettes in clinical diagnostics, genomics, and proteomics research applications across European countries and rising awareness about the importance of accurate and reproducible laboratory results fuels the adoption of high-quality serological pipettes drives the growth of the European market. Germany accounted for the leading share of the European market in 2022 and is expected to continue the lead during the forecast period.

APAC is the most lucrative regional market for serological pipettes worldwide and is projected to register the highest CAGR in the coming years. The rapid growth of the pharmaceutical and biotechnology industries in countries like China and India is driving the demand for serological pipettes in drug development and research applications and propelling the APAC market growth. The growing number of initiatives from the governments of APAC countries to enhance healthcare infrastructure and promote research and development in life sciences and increasing investments in precision medicine, genomics, and proteomics research that create demand for precise liquid handling tools like serological pipettes further promote the growth of the APAC market.

KEY MARKET PLAYERS:

Thermo Fisher Scientific Inc., Corning Incorporated, Eppendorf AG, Greiner Bio-One International GmbH, Merck KGaA, Sartorius AG, Bio-Rad Laboratories, Inc., BRAND GMBH + CO KG, Tarsons Products Pvt. Ltd. and Sarstedt AG & Co. KG are some of the major companies in the global serological pipettes market.

RECENT HAPPENINGS IN THE MARKET:

• In May 2023, the PIPETBOY acu 2 pipette controller from INTEGRA Biosciences is helping researchers in the Immune Sensing and Signalling Dynamics group/ImmunoHUB at the i3S in Porto, Portugal, to advance their research into the role of the aryl hydrocarbon receptor (AHR) in infection and cancer.